These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 21946775)
1. Biomarkers: Coronary artery calcium is a better risk marker than hsCRP. Alexopoulos N; Raggi P Nat Rev Cardiol; 2011 Sep; 8(11):616-8. PubMed ID: 21946775 [No Abstract] [Full Text] [Related]
2. Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium. Qureshi WT; Rana JS; Yeboah J; Bin Nasir U; Al-Mallah MH Curr Cardiol Rep; 2015 Dec; 17(12):110. PubMed ID: 26482753 [TBL] [Abstract][Full Text] [Related]
3. Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. Redberg RF; Rifai N; Gee L; Ridker PM J Am Coll Cardiol; 2000 Jul; 36(1):39-43. PubMed ID: 10898410 [TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and coronary calcium score association in coronary artery disease. Hosseinsabet A; Mohebbi A; Almasi A Cardiol J; 2008; 15(5):431-6. PubMed ID: 18810717 [TBL] [Abstract][Full Text] [Related]
5. Association of C-reactive protein with the presence and extent of angiographically verified coronary artery disease. Memon L; Spasojević-Kalimanovska V; Bogavac-Stanojević N; Kalimanovska-Ostrić D; Jelić-Ivanović Z; Spasić S; Topić A Tohoku J Exp Med; 2006 Jul; 209(3):197-206. PubMed ID: 16778366 [TBL] [Abstract][Full Text] [Related]
6. The clinical role of combined serum C1q and hsCRP in predicting coronary artery disease. Jia Y; Wen W; Yang Y; Huang M; Ning Y; Jiao X; Liu S; Qin Y; Zhang M Clin Biochem; 2021 Jul; 93():50-58. PubMed ID: 33861985 [TBL] [Abstract][Full Text] [Related]
7. Plasma pentraxin 3 is a more potent predictor of endothelial dysfunction than high-sensitive C-reactive protein. Yasunaga T; Ikeda S; Koga S; Nakata T; Yoshida T; Masuda N; Kohno S; Maemura K Int Heart J; 2014; 55(2):160-4. PubMed ID: 24632958 [TBL] [Abstract][Full Text] [Related]
8. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. Arad Y; Goodman KJ; Roth M; Newstein D; Guerci AD J Am Coll Cardiol; 2005 Jul; 46(1):158-65. PubMed ID: 15992651 [TBL] [Abstract][Full Text] [Related]
9. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound. Nasu K; Tsuchikane E; Katoh O; Tanaka N; Kimura M; Ehara M; Kinoshita Y; Matsubara T; Matsuo H; Asakura K; Asakura Y; Terashima M; Takayama T; Honye J; Hirayama A; Saito S; Suzuki T JACC Cardiovasc Interv; 2009 Jul; 2(7):689-96. PubMed ID: 19628194 [TBL] [Abstract][Full Text] [Related]
11. [Screening of asymptomatic individuals for coronary disease using CT-calcium measurement in the coronary arteries]. Schuijf JD; Bax JJ; Jukema JW; van der Wall EE Ned Tijdschr Geneeskd; 2006 Mar; 150(11):597-600. PubMed ID: 16610496 [TBL] [Abstract][Full Text] [Related]
13. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Sentürk T; Cordan J; Baran I; Ozdemir B; Güllülü S; Aydinlar A; Göral G Acta Cardiol; 2007 Apr; 62(2):135-41. PubMed ID: 17536601 [TBL] [Abstract][Full Text] [Related]
14. [A contemporary role of coronary artery calcium scoring in the assessment of the risk for coronary artery disease]. Gasior Z; Pysz P; Dabek J Pol Arch Med Wewn; 2007 Mar; 117(3):31-4. PubMed ID: 17718050 [TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine predicts progression of atherosclerosis. Rasouli ML; Nasir K; Blumenthal RS; Park R; Aziz DC; Budoff MJ Atherosclerosis; 2005 Jul; 181(1):159-65. PubMed ID: 15939068 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of C-reactive protein after drug-eluting stent implantation: an update view. Montone RA; Niccoli G Future Cardiol; 2018 Sep; 14(5):355-358. PubMed ID: 30232900 [No Abstract] [Full Text] [Related]
17. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease. Koc M; Karaarslan O; Abali G; Batur MK Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626 [TBL] [Abstract][Full Text] [Related]
18. What is C-reactive protein telling us about coronary artery disease? Levinson SS; Elin RJ Arch Intern Med; 2002 Feb; 162(4):389-92. PubMed ID: 11863469 [No Abstract] [Full Text] [Related]
19. Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality. Möhlenkamp S; Lehmann N; Moebus S; Schmermund A; Dragano N; Stang A; Siegrist J; Mann K; Jöckel KH; Erbel R; J Am Coll Cardiol; 2011 Mar; 57(13):1455-64. PubMed ID: 21435514 [TBL] [Abstract][Full Text] [Related]
20. Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study. Kara K; Mahabadi AA; Berg MH; Lehmann N; Möhlenkamp S; Kälsch H; Bauer M; Moebus S; Dragano N; Jöckel KH; Neumann T; Erbel R Eur J Prev Cardiol; 2014 Sep; 21(9):1171-9. PubMed ID: 23674833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]